Location History:
- Rockville, IN (US) (1990)
- Greenwood, IN (US) (1996 - 2019)
Company Filing History:
Years Active: 1990-2019
Title: The Innovative Contributions of James Denmore Copp
Introduction
James Denmore Copp, an accomplished inventor based in Greenwood, Indiana, USA, has made significant contributions to the field of medicinal chemistry. With a total of six patents to his name, Copp's work focuses on developing innovative compounds with therapeutic applications.
Latest Patents
Copp's latest patents highlight his expertise in the synthesis of valuable chemical compounds. One of his notable inventions is the process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters, and amides. This patent discloses methods for creating these compounds, including derivatives such as 5-aryl substituted and 5-heteroaryl substituted [(3-hydroxypyridine-2-carbonyl]amino}acetic acids. Additionally, it outlines techniques for producing prodrugs of these acids, enhancing their utility as prolyl hydroxylase inhibitors for various medical conditions. Another important aspect of his work includes compounds of general structural formula (I), which serve as therapeutic agents for treating cardiovascular disorders by inhibiting phosphodiesterase 5.
Career Highlights
Throughout his career, James Denmore Copp has collaborated with prominent companies, including Eli Lilly and Company and Lilly Icos LLC. His work in these organizations has been instrumental in advancing pharmaceutical research and development, particularly in the realm of innovative chemical solutions for healthcare.
Collaborations
Copp's achievements have been further enriched by his collaborations with accomplished coworkers, notably Francis O Ginah and Marvin M Hansen. These partnerships have fostered a creative and productive environment, leading to significant advancements in medicinal chemistry and the development of new therapeutic agents.
Conclusion
In summary, James Denmore Copp's inventive spirit and dedication to advancing medical science are evident in his numerous patents and collaborative efforts. His work continues to impact the pharmaceutical industry, offering innovative solutions for treating serious health conditions and improving patient outcomes.